Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 10, 2015 2:16 AM ET

Diversified Consumer Services

Company Overview of Johns Hopkins University

Company Overview

Johns Hopkins University is an educational institution that offers undergraduate, graduate, part-time, summer, and distance education programs in the arts and music, humanities, social and natural sciences, engineering, international studies, education, business, and the health professions. Johns Hopkins University was incorporated in 1867 and is based in Baltimore, Maryland.

3400 North Charles Street

Baltimore, MD 21218-2683

United States

Founded in 1867





Key Executives for Johns Hopkins University

Executive Director of Communications and Public Affairs
Chief Investment Officer
Vice President of Communications and Public Affairs
Director of Alumni Relations
Compensation as of Fiscal Year 2015.

Johns Hopkins University Key Developments

Johns Hopkins University LLC Wins $1.17 Million Task Order

Johns Hopkins University LLC won a $1,167,008 task order from the U.S. Department of Defense for the technical analysis of strategic strike capabilities.

Johns Hopkins University Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-08-2015 05:45 PM

Johns Hopkins University Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-08-2015 05:45 PM. Venue: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: Jennifer Elisseeff, Director, Translational Tissue Engineering Center.

Progenics Pharmaceuticals Enters into Licensing Agreement with Johns Hopkins

Progenics Pharmaceuticals Inc. has entered into an exclusive worldwide licensing agreement with Johns Hopkins University for 18F-DCFPyL, or PyL, a clinical-stage prostate specific membrane antigen, or PSMA, targeted imaging agent for prostate cancer. PyL, when used in conjunction with high-resolution PET imaging, has shown potential for use in identifying prostate cancer and sites of relapse. PyL was developed by a team led by Martin G. Pomper, M.D., Ph.D. at the Johns Hopkins University School of Medicine. An early stage clinical trial of PyL with PET imaging in men with prostate cancer demonstrated uptake of PyL in sites of putative metastatic disease and primary tumors not seen with currently approved imaging techniques, suggesting the potential for high sensitivity and specificity in detecting prostate cancer.

Similar Private Companies By Industry

Company Name Region
Gary S. Olshan P.C. United States
21st Century Automotive Collision Repair Specialist, Inc. United States
Deering Cleaners Downtown United States
Penton Learning Systems, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Johns Hopkins University, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at